
SynBioBeta Speaker
Katie Galloway
Assistant Professor
MIT
Over the last decade, advances in genome engineering and stem cell biology have massively expanded the potential of engineered cells as therapeutics. However, engineering mammalian cells remains limited by inefficient methods of genome engineering, slow workflows, and unpredictable outcomes. As a chemical engineer working at the intersection of stem cell biology, synthetic biology, and molecular systems biology, I aim to make the programming of human cells fast, reliable, and efficient. Using a combination of molecular engineering and computational modeling, my lab is accelerating the rate at which we develop genetic programs to scalably engineer cells for diverse applications in biotechnology and biomedical research including neuron replacement therapies.
SynBioBeta 2025 - Session Speaker
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include

2026
Event Updates














































































































































































































































































































































































































































